Swiss drug developer Basilea Pharmaceutica has entered into an exclusive license agreement with Venatorx Pharmaceuticals, to ...

Flagship Pioneering has appointed Ajit Singh as chief executive (CEO)-partner of Flagship and the new CEO of Harbinger Health ...

US pharma major Eli Lilly is raising the list price for its obesity drug Mounjaro (tirzepatide) in the UK by as much as 170%, as the pharma industry comes under pressure from US President Donald Trump ...